Omeprazole and Lenticular opacities - a phase IV clinical study of FDA data

Summary:

Lenticular opacities is reported as a side effect among people who take Omeprazole (omeprazole), especially for people who are male, 50-59 old, also take Orfadin, and have Alkaptonuria.

The phase IV clinical study analyzes which people have Lenticular opacities when taking Omeprazole. It is created by eHealthMe based on reports of 400,982 people who have side effects when taking Omeprazole from the FDA, and is updated regularly.

What is Omeprazole?

Omeprazole has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 410,631 Omeprazole users. Check the latest studies of Omeprazole.

What is Lenticular opacities?

Lenticular opacities (swelling and opacity of the entire lens) is found to be associated with 73 drugs and 152 conditions by eHealthMe. Check the latest studies of Lenticular opacities.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

400,982 people reported to have side effects when taking Omeprazole.
Among them, 46 people (0.01%) have Lenticular opacities.

Could Omeprazole cause Lenticular opacities?

Among these 46 people:

What is the gender of people who have Lenticular opacities when taking Omeprazole? *

female: 39.13 %
male: 60.87 %

What is the age of people who have Lenticular opacities when taking Omeprazole? *

What are other drugs people take besides Omeprazole? *

What are other side effects people have besides Lenticular opacities? *

Cataract (clouding of the lens inside the eye): 35 people, 76.09%
Amino Acid Level Increased: 34 people, 73.91%
Visual Acuity Reduced (reduced clearness of vision): 10 people, 21.74%
Conjunctivitis (pink eye): 7 people, 15.22%
Conjunctival Oedema (conjunctival swelling): 7 people, 15.22%
Vision Blurred: 6 people, 13.04%
Impaired Driving Ability: 5 people, 10.87%
Nearsightedness (difficulty in seeing the far objects): 5 people, 10.87%
Muscle Aches (muscle pain): 5 people, 10.87%
Lens Disorder (lens disease): 5 people, 10.87%

What are the existing conditions these people have? *

Alkaptonuria (black urine disease): 34 people, 73.91%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 3 people, 6.52%
Pain: 1 person, 2.17%
Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 1 person, 2.17%
High Blood Cholesterol: 1 person, 2.17%
Hereditary Neuropathic Amyloidosis (hereditary- diseases resulting from abnormal deposition of certain proteins (amyloid) in various bodily areas by problems with signals from the nerves): 1 person, 2.17%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 1 person, 2.17%
Diabetes: 1 person, 2.17%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 2.17%

* Approximation only. Some reports may have incomplete information.

Do you take Omeprazole and have Lenticular opacities?

- Check whether Lenticular opacities is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Omeprazole:

Omeprazole (410,631 reports)

Browse all side effects of Omeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lenticular opacities:

Lenticular opacities (73 drugs)

Browse all the conditions that are associated with Lenticular opacities:

Lenticular opacities (152 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on omeprazole (the active ingredients of Omeprazole) and Omeprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.